Shares of VIVUS, Inc. (NASDAQ:
VVUS) shares are higher today, gaining 96 cents to $7.27, a gain of over 15% after the company shared positive data on its weight loss drug, Qnexa.
VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
